Form 8-K AMEDISYS INC For: Aug 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
UPDATE: Amedisys (AMED) Reports In-Line EPS, Revenue Tops Views; CFO to Retire
August 2, 2016 5:19 PM EDT(Updated - August 2, 2016 5:47 PM EDT)
(Update corrects for adjusted EPS figure)
Amedisys (NASDAQ: AMED) reported Q2 EPS of $0.42 vs consensus of $0.42. Revenue for the quarter came in at $360 million versus the consensus estimate of $353.07 million.
Executive Retirement
On August 2, 2016, Ronald A. LaBorde, the Vice Chairman and... More
